Position in SEPN
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$23,212
-$4,361 QoQ
Shares Held
966
-2.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in SEPN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SIGNATUREFD, LLC holds $11,812,434 across 171 Biotechnology names. SEPN ranks #61 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,526 | $2,467,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,995 | $1,541,416 | |
| 3 | ARGX |
Argenx SE
|
1,813 | $1,323,943 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,047 | $677,290 | |
| 5 | GMAB |
Genmab A/S
|
15,780 | $423,377 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
7,120 | $413,743 | |
| 7 | INCY |
Incyte Corp
|
3,385 | $318,596 | |
| 8 | EXEL |
Exelixis, Inc.
|
6,054 | $259,656 |
All Filings in SEPN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,212 | 966 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $27,573 | 989 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $18,170 | 966 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $10,210 | 966 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||